NO983829D0 - Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)£1,4|diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer - Google Patents
Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)£1,4|diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommerInfo
- Publication number
- NO983829D0 NO983829D0 NO983829A NO983829A NO983829D0 NO 983829 D0 NO983829 D0 NO 983829D0 NO 983829 A NO983829 A NO 983829A NO 983829 A NO983829 A NO 983829A NO 983829 D0 NO983829 D0 NO 983829D0
- Authority
- NO
- Norway
- Prior art keywords
- diazepan
- benzimidazol
- aryl
- butyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60459096A | 1996-02-21 | 1996-02-21 | |
| US78199797A | 1997-01-06 | 1997-01-06 | |
| PCT/US1997/001601 WO1997030991A1 (en) | 1996-02-21 | 1997-01-29 | Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983829D0 true NO983829D0 (no) | 1998-08-20 |
| NO983829L NO983829L (no) | 1998-10-20 |
Family
ID=27084698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983829A NO983829L (no) | 1996-02-21 | 1998-08-20 | Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0888338B1 (no) |
| JP (1) | JP2000505083A (no) |
| KR (1) | KR19990087130A (no) |
| CN (1) | CN1143856C (no) |
| AR (1) | AR005897A1 (no) |
| AT (1) | ATE282609T1 (no) |
| AU (1) | AU708738B2 (no) |
| BR (1) | BR9710712A (no) |
| CA (1) | CA2246994C (no) |
| DE (1) | DE69731620D1 (no) |
| HU (1) | HUP9900401A3 (no) |
| IL (1) | IL125605A0 (no) |
| NO (1) | NO983829L (no) |
| NZ (1) | NZ330909A (no) |
| TW (1) | TW440565B (no) |
| WO (1) | WO1997030991A1 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6423704B2 (en) | 1995-12-20 | 2002-07-23 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| US6194406B1 (en) | 1995-12-20 | 2001-02-27 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease |
| US7030150B2 (en) * | 2001-05-11 | 2006-04-18 | Trimeris, Inc. | Benzimidazole compounds and antiviral uses thereof |
| BRPI0807972A2 (pt) | 2007-01-24 | 2014-06-10 | Glaxo Group Ltd | Composições farmacêuticas compreendendo 3,5-diamino-6-(2,3-diclofenil)-l,2,4-triazina ou r(-)-2,4-diamino-5-(2,3-diclorofenil)-6-fluorometilpirim idina e uma nk1 |
| CN112778279B (zh) * | 2021-01-25 | 2021-09-28 | 苏州正永生物医药有限公司 | 一种依美斯汀化合物的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5879983A (ja) * | 1981-11-06 | 1983-05-13 | Kanebo Ltd | 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物 |
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
| GB9310713D0 (en) * | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
| CA2198084C (en) * | 1994-08-25 | 2000-03-28 | Timothy P. Burkholder | Novel substituted piperidines useful for the treatment of allergic diseases |
| US5607936A (en) * | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
-
1997
- 1997-01-29 CA CA002246994A patent/CA2246994C/en not_active Expired - Fee Related
- 1997-01-29 HU HU9900401A patent/HUP9900401A3/hu unknown
- 1997-01-29 AT AT97905700T patent/ATE282609T1/de not_active IP Right Cessation
- 1997-01-29 AU AU22531/97A patent/AU708738B2/en not_active Ceased
- 1997-01-29 JP JP9530170A patent/JP2000505083A/ja not_active Abandoned
- 1997-01-29 KR KR1019980706521A patent/KR19990087130A/ko not_active Application Discontinuation
- 1997-01-29 EP EP97905700A patent/EP0888338B1/en not_active Expired - Lifetime
- 1997-01-29 NZ NZ330909A patent/NZ330909A/en unknown
- 1997-01-29 CN CNB971923833A patent/CN1143856C/zh not_active Expired - Fee Related
- 1997-01-29 BR BR9710712A patent/BR9710712A/pt not_active IP Right Cessation
- 1997-01-29 IL IL12560597A patent/IL125605A0/xx unknown
- 1997-01-29 WO PCT/US1997/001601 patent/WO1997030991A1/en active IP Right Grant
- 1997-01-29 DE DE69731620T patent/DE69731620D1/de not_active Expired - Lifetime
- 1997-02-18 TW TW086101884A patent/TW440565B/zh not_active IP Right Cessation
- 1997-02-19 AR ARP970100646A patent/AR005897A1/es not_active Application Discontinuation
-
1998
- 1998-08-20 NO NO983829A patent/NO983829L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9710712A (pt) | 1999-08-17 |
| HUP9900401A2 (hu) | 2000-03-28 |
| ATE282609T1 (de) | 2004-12-15 |
| CA2246994C (en) | 2002-04-30 |
| CN1211248A (zh) | 1999-03-17 |
| DE69731620D1 (de) | 2004-12-23 |
| CA2246994A1 (en) | 1997-08-28 |
| NZ330909A (en) | 2001-04-27 |
| EP0888338B1 (en) | 2004-11-17 |
| WO1997030991A1 (en) | 1997-08-28 |
| KR19990087130A (ko) | 1999-12-15 |
| JP2000505083A (ja) | 2000-04-25 |
| AU2253197A (en) | 1997-09-10 |
| CN1143856C (zh) | 2004-03-31 |
| AU708738B2 (en) | 1999-08-12 |
| TW440565B (en) | 2001-06-16 |
| HUP9900401A3 (en) | 2002-10-28 |
| EP0888338A1 (en) | 1999-01-07 |
| AR005897A1 (es) | 1999-07-21 |
| IL125605A0 (en) | 1999-03-12 |
| NO983829L (no) | 1998-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID26043A (id) | Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv | |
| ID26420A (id) | Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi | |
| FI972684A0 (fi) | Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina | |
| NO982867L (no) | Nye substituerte 4-(1H-benzimidazol-2-yl)£1,4|diazepaner som er anvendbare for behandling av allergiske sykdommer | |
| ITMI940317A0 (it) | Procedimento per la produzione di gamma-butirrolattone | |
| NO983829D0 (no) | Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)£1,4|diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer | |
| PT790236E (pt) | Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona | |
| ID30562A (id) | Senyawa-senyawa amina aromatik tersubstitusi ribosa baru, metode pembuatannya dan penggunaannya sebagai obat | |
| NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| NO20005216D0 (no) | Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon | |
| HUP9901751A3 (en) | Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases | |
| NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
| NO983830L (no) | Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer | |
| EE200200670A (et) | S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks | |
| ID20165A (id) | Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis | |
| NO20012540D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| ZA971321B (en) | Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamide useful for the treatment of allergic diseases. | |
| ZA962060B (en) | Topical ophthalmic composition comprising a 2-(4-(azolylbutyl)-piperazinyl)benzimidazole derivative in particular for the treatment of allergic conjunctivitis | |
| ITMI972622A1 (it) | Derivati del 2-fenilazulene e metodo per la produzione di questi composti | |
| NO910633D0 (no) | Fremgangsmaate for syntese av oligomerer av (metylbenzyl)-xylen og deres anvendelse som dielektrika. | |
| NO985558D0 (no) | Ny forbedret formulering for behandling av tromboembolisme | |
| ITMI951587A0 (it) | Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5-afa-androst-1-ene-17beta-carbossammide | |
| NO20005856L (no) | Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner | |
| SI0874843T1 (en) | Substituted 4-(1h-benzimidazol-2-yl) 1,4)diazepanes useful for the treatment of allergic diseases | |
| SI0888336T1 (en) | Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |